![Ragnhild Marie Løberg](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ragnhild Marie Løberg
Nessuna posizione attualmente
Profilo
Ragnhild Marie Løberg formerly worked at Pronova AS, as Director-Galenical Department, Pronova Biocare AS, as Quality Director in 2002, and Algeta ASA, as Senior Vice President-Quality & Regulatory Affairs.
Ms. Løberg received her graduate degree in 1978 from the University of Oslo.
Precedenti posizioni note di Ragnhild Marie Løberg
Società | Posizione | Fine |
---|---|---|
Pronova Biocare AS | Corporate Officer/Principal | 01/01/2002 |
ALGETA ASA | Consigliere Generale | - |
Pronova AS
![]() Pronova AS Investment Banks/BrokersFinance Part of Norsk Hydro ASA, Pronova AS provides non-marine broking services. | Corporate Officer/Principal | - |
Formazione di Ragnhild Marie Løberg
University of Oslo | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 3 |
---|---|
Pronova AS
![]() Pronova AS Investment Banks/BrokersFinance Part of Norsk Hydro ASA, Pronova AS provides non-marine broking services. | Finance |
Algeta ASA
![]() Algeta ASA Pharmaceuticals: MajorHealth Technology Algeta ASA is engaged in the development of products for the treatment of cancer. The company focuses on the development of anti-cancer drugs, and its research and development of compounds focuses on the various applications of a few base compounds. Its products, Alpharadin and Thorium-227, are being developed for treatment of skeletal metastases originating from prostate and breast cancer. The company was founded by Roy H. Larsen and Øyvind Sverre Bruland in 1997 and is headquartered in Oslo, Norway. | Health Technology |
Pronova Biocare AS |
- Borsa valori
- Insiders
- Ragnhild Marie Løberg